Showing 1–24 of 24 results
-
Research |
Lomustine is beneficial to older AML with ELN2017 adverse risk profile and intermediate karyotype: a FILO study
- Laetitia Largeaud
- , Pascale Cornillet-Lefebvre
- , Jean-François Hamel
- , Pierre-Yves Dumas
- , Naïs Prade
- , Stéphanie Dufrechou
- , Julien Plenecassagnes
- , Isabelle Luquet
- , Odile Blanchet
- , Anne Banos
- , Marie C. Béné
- , Marc Bernard
- , Sarah Bertoli
- , Caroline Bonmati
- , Luc Matthieu Fornecker
- , Romain Guièze
- , Lamya Haddaoui
- , Mathilde Hunault
- , Jean Christophe Ianotto
- , Eric Jourdan
- , Mario Ojeda
- , Pierre Peterlin
- , Norbert Vey
- , Hacene Zerazhi
- , Hicheri Yosr
- , Ariane Mineur
- , Jean-Yves Cahn
- , Norbert Ifrah
- , Christian Récher
- , Arnaud Pigneux
- , Eric Delabesse
- , J.-P. Marolleau
- , A. Aleme
- , F. Orsini-Piocelle
- , N. Cadoux
- , N. Ifrah
- , M. Hunault
- , C. Marie
- , A. Al Jijakli
- , G. Lepeu
- , H. Zerazhi
- , M. Beyrne
- , A. Banos
- , S. Labarrere
- , E. Deconinck
- , M. Peria
- , A. El Yamani
- , O. Kadiri
- , B. Choufi
- , M. Brument
- , A. Pigneux
- , T. Leguay
- , P.-Y. Dumas
- , C. Berthou
- , G. Guillerm
- , G. Drugmanne
- , O. Tournilhac
- , G. Roy
- , B. Audhuy
- , S. Camara
- , D. Caillot
- , M. Grandjean
- , J.-Y. Cahn
- , C.-E. Bulabois
- , B. Fief
- , N. Vey
- , C. Ladraa
- , V. Dorvaux
- , M. Hagopian
- , N. Fegueux
- , C. Fenoll
- , V. Sabadash
- , M. Ojeda
- , C. Haby
- , F. Witz
- , C. Bonmati
- , M. Lhuire
- , J. Delaunay
- , P. Peterlin
- , L. Airiau
- , L. Mannone
- , I. Touitou
- , E. Jourdan
- , D. Umuhire
- , M. Alexis
- , O. Michel
- , F. Dreyfus
- , D. Bouscary
- , A. Cheung
- , L. Sanhes
- , F. Touhami
- , E. Ribas
- , M. Puyade
- , M.-P. Gallego-Hernanz
- , N. Hugon
- , C. Himberlin
- , L. Maggi
- , T. Lamy
- , A. Testu
- , E. Tavernier
- , S. Marchand
- , B. Lioure
- , C. Kravanja
- , L. Benboubker
- , D. Nollet
- , M. Attal
- , C. Recher
- , A. Sarry
- , A. Lhermitte
- , G. Yrica
- , D. Schwartz
- , N. Le Montagner
- , C. Fenoll
- , V. Sabadash
- , D. Nollet
- , L. Auvray
- , R. Delepine
- & A. Fayault
-
Correspondence |
-
-
Amendments and Corrections |
Erratum: Deletion of the 1p32 region is a major independent prognostic factor in young patients with myeloma: the IFM experience on 1195 patients
- B Hebraud
- , X Leleu
- , V Lauwers-Cances
- , M Roussel
- , D Caillot
- , G Marit
- , L Karlin
- , C Hulin
- , C Gentil
- , F Guilhot
- , L Garderet
- , T Lamy
- , S Brechignac
- , B Pegourie
- , J Jaubert
- , M Dib
- , A-M Stoppa
- , C Sebban
- , C Fohrer
- , J Fontan
- , C Fruchart
- , M Macro
- , F Orsini-Piocelle
- , G Lepeu
- , C Sohn
- , J Corre
- , T Facon
- , P Moreau
- , M Attal
- & H Avet-Loiseau
-
Research |
Effect of immune modulation in relapsed peripheral T-cell lymphomas after post-allogeneic stem cell transplantation: a study by the Société Française de Greffe de Moelle et de Thérapie Cellulaire (SFGM-TC)
- A-C Mamez
- , V Lévy
- , P Chevallier
- , D Blaise
- , S Vigouroux
- , A Xhaard
- , N Fegueux
- , N Contentin
- , Y Beguin
- , N Ifrah
- , C-E Bulabois
- , F Suarez
- , I Yakoub-Agha
- , P Turlure
- , E Deconink
- , T Lamy
- , J Y Cahn
- , A Huynh
- , S Maury
- , L M Fornecker
- , M Ouzegdouh
- , J-O Bay
- , G Guillerm
- , N Maillard
- , M Michallet
- , J-V Malfuson
- , J-H Bourhis
- , F Rialland
- , R Oumedaly
- , C Jubert
- , V Leblond
- , M Boubaya
- , M Mohty
- & S Nguyen
Bone Marrow Transplantation 51 , 358–364 -
Research |
Deletion of the 1p32 region is a major independent prognostic factor in young patients with myeloma: the IFM experience on 1195 patients
- B Hebraud
- , X Leleu
- , V Lauwers-Cances
- , M Roussel
- , D Caillot
- , G Marit
- , L Karlin
- , C Hulin
- , C Gentil
- , F Guilhot
- , L Garderet
- , T Lamy
- , S Brechignac
- , B Pegourie
- , J Jaubert
- , M Dib
- , A-M Stoppa
- , C Sebban
- , C Fohrer
- , J Fontan
- , C Fruchart
- , M Macro
- , F Orsini-Piocelle
- , G Lepeu
- , C Sohn
- , J Corre
- , T Facon
- , P Moreau
- , M Attal
- & H Avet-Loiseau
-
-
| Open
-
-
-
-
Research |
Heterogeneity of t(4;14) in multiple myeloma. Long-term follow-up of 100 cases treated with tandem transplantation in IFM99 trials
- P Moreau
- , M Attal
- , F Garban
- , C Hulin
- , T Facon
- , G Marit
- , M Michallet
- , C Doyen
- , S Leyvraz
- , M Mohty
- , M Wetterwald
- , C Mathiot
- , D Caillot
- , C Berthou
- , L Benboubker
- , L Garderet
- , C Chaleteix
- , C Traullé
- , J G Fuzibet
- , J Jaubert
- , T Lamy
- , P Casassus
- , M Dib
- , B Kolb
- , V Dorvaux
- , B Grosbois
- , I Yakoub-Agha
- , J L Harousseau
- & H Avet-Loiseau
-
-
Research |
-
Research |
-
Research |
-
-
-
Correspondence |
-
Research |
High level of soluble programmed cell death ligand 1 in blood impacts overall survival in aggressive diffuse large B-Cell lymphoma: results from a French multicenter clinical trial
- D Rossille
- , M Gressier
- , D Damotte
- , D Maucort-Boulch
- , C Pangault
- , G Semana
- , S Le Gouill
- , C Haioun
- , K Tarte
- , T Lamy
- , N Milpied
- , T Fest
- , G Damaj
- , A Clavert
- , A Al Jijakli
- , A Banos
- , J-L Dutel
- , E Deconinck
- , P Rodon
- , K Bouabdallah
- , P Soubeyran
- , B Choufi
- , A Maakaroun
- , O Tournilhac
- , J Fleury
- , R Gressin
- , H Maisonneuve
- , K Laribi
- , P Solal-Celigny
- , P Moreau
- , J-F Rossi
- , G Cartron
- , N Morineau
- , J L Harousseau
- , E Jourdan
- , M Alexis
- , F Dreyfus
- , V Delwail
- , J Cornillon
- , R Garidi
- , E Gyan
- , P Colombat
- & P Godemer
-
Research |
-
Research |
-
Research |
-
Research |
